Karen McCoy

Karen McCoy's research focuses on cystic fibrosis (CF), a genetic disease that causes thick mucus buildup affecting the lungs, digestive system, and other organs. Her work spans clinical trials of new CF drugs (including CFTR modulators and inhaled therapies), studies of lung disease progression in children, and research on co-occurring conditions such as autism spectrum disorder in CF patients. Much of her work involves multicenter clinical studies evaluating drug safety, effectiveness, and impact on lung function, bacterial infections, and immune responses.

Publication output has remained fairly steady over the past decade, averaging just under 7 papers per year in the last 5 years, with a notable peak in 2023.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026